Evaluation and Treatment of Patients With Dermatologic Diseases

NCT00001506 | Completed

• 2 other identifiers: 96010296-AR-0102
• Study Type: observational
• Target: 453
• Locations: 1 country
• Sites: 1

Brief Summary

This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.

Conditions

Dermatologic Diseases; Systemic Diseases With Cutaneous Manifestations

Keywords

Training; Standard Therapy; Standard Tests; Natural History; Consultation

Outcome Measures

Primary Outcomes (2)

• Provide clinical material

  Provide clinical material

  Ongoing

• Natural history of selected dermatologic diseases

  Natural history of selected dermatologic diseases

  Ongoing

Study Arms (1)

Patients

With dermatologic diseases and systemic diseases with cutaneous manifestations

Eligibility Criteria

• Age: 1 Day - 120 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with dermatologic diseases and systemic diseases with cutaneous manifestations

You may qualify if:

• Patients of any age (only viable neonates will enroll in the study), of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations that will help the Branch fulfill the objectives.
• Women who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child.
• Patients must have a referring physician who will continue to assume primary medical responsibility of care for the patient during and after enrollment in this protocol.

You may not qualify if:

• Any participant who, in the investigator s opinion, would be unable to comply with study requirements or for whom participation may pose a greater medical risk.

Sponsors & Collaborators

• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): lead

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

• NIH Clinical Center Detailed Web Page

MeSH Terms

Conditions

Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Study Officials

• Edward W Cowen, M.D.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 3, 1999
• First Posted: November 4, 1999
• Study Start: August 22, 1996
• Primary Completion: March 26, 2025
• Study Completion: April 1, 2025
• Last Updated: April 13, 2025

Record last verified: 2025-04

Locations

US (1)